Both in Pharmaceuticals
Savara vs MoonLake Immunotherapeutics
Over the past year SVRA returned +11.2% and MLTX returned +14.7%; their daily moves had a correlation of 0.27.
SVRA +11.2% MLTX +14.7%Growth of $1, one year, split-adjusted
| Metric | SVRA | MLTX |
|---|---|---|
| Price | $4.75 | $11.70 |
| Market cap | $975.9M | $995.7M |
| Today | +0.42% | +2.01% |
| 1 month | −0.6% | +2.8% |
| 6 months | −9.5% | −31.2% |
| Year to date | −21.2% | −11.2% |
| 1 year | +14.5% | +15.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $142.9M | $437.5M |
| Dividend yield | — | — |
| Volatility (60d) | 48.5% | 57.5% |
| Short % of float | 20.1% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).